Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy
Completed · Phase 1
Conditions studied: Epilepsy
In brief
To investigate whether MR-guided laser induced thermal therapy in patients diagnosed with focal lesional epilepsy using the Visualase Thermal Therapy System is both a feasible and safe minimally invasive technique for control of seizures in such patients.
Key facts
- Study ID
- NCT01703143
- Run by
- Mayo Clinic
- People needed
- 14
- Starts
- 2011-05-01
- Expected to finish
- 2015-01-01
- Last updated by the study team
- 2015-01-26
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years or older at entry to protocol.
- History of MRI lesional-related epilepsy for at least one year.
- Failure to respond to more than 2 anti-epileptic drugs at adequate dose and duration.
- Candidate for resective epilepsy surgery.
- Considered healthy enough to undergo surgery with general anesthesia.
- The patient has given written informed consent after the nature of the study and alternative treatment options have been explained.
- Must have 3 months of seizure frequency recorded prior to procedure.
You may not qualify if…
- Presence of any non-MRI compatible implanted electronic device.
- Presence of a metallic prosthetic or implant including artificial hips, knees, joints, or rods and screws.
- Active Major depression
- History of Suicide attempts
- History of Non-Epileptic Behavioral Spells
Where it is running
- Mayo Clinic in Florida — Jacksonville, Florida, United States
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.